WO/2002/012341 is referenced by 3 patents.

The present invention is generally directed to Her-2/neu fusion proteins, nucleic acid molecules encoding Her-2/neu fusion proteins, viral vectors expressing Her-2/neu fusion proteins, and pharmaceutical compositions (e.g., vaccines) comprising the Her-2/neu fusion proteins and/or nucleic acid molecules encoding the Her-2/neu fusion proteins. The present invention is also directed to methods of treating or preventing cancer by eliciting or enhancing an immune response to the Her-2/neu protein, including for uses in the treatment of malignancies associated with the Her-2/neu oncogene.

Title
Her-2/neu fusion proteins
Application Number
PCT/US2001/024283
Publication Number
2002/012341
Application Date
August 3, 2001
Publication Date
February 14, 2002
Inventor
Gheysen Dirk
Cheever Martin A
Agent
PARENT Annette S
Assignee
Gheysen Dirk
Cheever Martin A
Smithkline Beecham Biologicals
Corixa Corporation
IPC
A61K 48/00
A61K 39/00
A61K 38/00
C07K 14/82
C07K 14/71
View Original Source